More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$4.57B
EPS
7.04
P/E ratio
18.9
Price to sales
2.33
Dividend yield
--
Beta
0.625946
Previous close
$133.58
Today's open
$133.66
Day's range
$132.98 - $135.88
52 week range
$86.97 - $156.26
show more
CEO
Stephen W. Beard
Employees
9938
Headquarters
Chicago, IL
Exchange
New York Stock Exchange
Shares outstanding
34038820
Issue type
Common Stock
Consumer Staples
Education
Here's Why Covista (CVSA) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • 17 hours ago

Here's Why Covista (CVSA) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Sep 2, 2026

Here's Why Covista (CVSA) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Aug 27, 2026

Covista: Strong Secular Growth And Operating Leverage
Covista is rated BUY, driven by secular healthcare education demand and 12 consecutive quarters of enrollment growth. CVSA's Q4 saw revenue up 9.7% and adjusted EPS up 25.9%, with all segments showing positive operating leverage and margin expansion. Strong cash flows, a declining leverage ratio, and $238m in share repurchases reinforce balance sheet strength and shareholder returns.
Seeking Alpha • Aug 14, 2026

Covista SVP Sells 4,526 Shares for $615,000
The disposition of 4,526 shares on August 7, 2026, realized a total value of ~$615,000. The transaction resulted in a 14% reduction in the insider's direct equity holdings.
The Motley Fool • Aug 13, 2026

Why Covista (CVSA) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Aug 10, 2026

Covista Q4 Earnings & Revenues Top Estimates, Enrollments Up Y/Y
CVSA posts double-digit profit growth, record Walden enrollment and raises fiscal 2027 targets as strong execution continued across all three segments.
Zacks Investment Research • Aug 7, 2026

Covista Inc. (CVSA) Q4 2026 Earnings Call Transcript
Covista Inc. (CVSA) Q4 2026 Earnings Call Transcript
Seeking Alpha • Aug 7, 2026

Covista (CVSA) Q4 Earnings and Revenues Top Estimates
Covista (CVSA) came out with quarterly earnings of $2.09 per share, beating the Zacks Consensus Estimate of $1.9 per share. This compares to earnings of $1.66 per share a year ago.
Zacks Investment Research • Aug 7, 2026

Covista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; Initiates Fiscal Year 2027 Guidance
CHICAGO--(BUSINESS WIRE)--Covista Inc. (NYSE: CVSA), America's largest healthcare educator, today reported fourth quarter and fiscal year 2026 results (ended June 30, 2026). The Company completed its three-year Growth with Purpose strategy and now embarks on its Purpose at Scale strategy, leading the transformation of higher education by training the next generation of healthcare professionals at an industry-leading scale. "We completed Growth with Purpose in a position of strength, exceeding b.
Business Wire • Aug 6, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Covista Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.